23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.

The David Rubenstein Show: Peer to Peer Conversations : BLOOMBERG : August 14, 2022 10:00am-10:30am EDT : Free Borrow & Streaming : Internet Archive

The 23andMe Incident Highlights Genetic Privacy Limits

23andMe Will Give GSK Access to Consumer DNA Data - Bloomberg

DNA Company 23andMe Gets FDA Approval for Consumer Cancer Test - Bloomberg

23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

FDA orders 23andMe to halt sales of DNA test kit - The Verge

Google-Backed 23andMe Genetic Testing Shuttered By FDA - SlashGear

GlaxoSmithKline Is Acquiring a $300 Million Stake in 23andMe

23andMe Is Really a Biotech Firm, Analyst Says - Barron's

DNA Testing Startup 23andMe Hits A Snag As FDA Shuts Down Sales Of Home Testing Kit

23andMe plans to move beyond genetic testing to making drugs - The Verge

Chinese Parents Test DNA to Check If Kids Will Become Prodigies - BNN Bloomberg

Tempus, Groupon Co-Founder's Medical Technically Startup, Is Exploring an IPO

23andMe Therapeutics: From Genes to Drugs